Organization | Department of Medical Research, Lower Myanmar

Department of Medical Research, Lower Myanmar Report issue

Academic/Hospital Phase 3

Founded: Yangon Myanmar

Organization Overview

First Clinical Trial

2009

NCT02792816

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 3 Trials (5)

dihydroqinghaosu (2 trials)

oz277 (1 trial)

piperaquinoline (2 trials)

vitamin a (1 trial)

Drugs in Other Trials (5)

artesunate (1 trial)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

mefloquine (lariam) (1 trial)

misoprostol (cytotec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Inflammation (Phase 3)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 4
# of Trial APIs: 10